SCHEMBL30512593

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)CC)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR1	P32241	4/20	0.47

▸	VIPR2	P41587	6/20	0.46

▸	RXFP1	Q9HBX9	2/20	0.43

▸	CXCR4	P61073	1/20	0.43

▸	CCNA2	P20248	2/20	0.43

▸	CDK2	P24941	2/20	0.43

▸	CCNA1	P78396	2/20	0.43

▸	GRIN2D	O15399	1/20	0.43

▸	GRIN3B	O60391	1/20	0.43

▸	GRIN1	Q05586	1/20	0.43

▸	GRIN2A	Q12879	1/20	0.43

▸	GRIN2B	Q13224	1/20	0.43

▸	GRIN2C	Q14957	1/20	0.43

▸	GRIN3A	Q8TCU5	1/20	0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29856153	0.91	TFPI (0.47)	VIPR1VIPR2
SCHEMBL29965025	0.89	VIPR1 (0.56)	VIPR1VIPR2RXFP1GRIN2DGRIN3B
SCHEMBL31501225	0.88	CCNA2 (0.46)	VIPR1VIPR2RXFP1CCNA2CDK2
SCHEMBL30179580	0.88	VIPR1 (0.53)	VIPR1VIPR2RXFP1
SCHEMBL29593786	0.88	VIPR1 (0.48)	VIPR1VIPR2CXCR4
SCHEMBL29473651	0.88	VIPR1 (0.53)	VIPR1VIPR2RXFP1GRIN2DGRIN3B
SCHEMBL30512496	0.86	RXFP1 (0.51)	VIPR1VIPR2RXFP1CCNA2CDK2
SCHEMBL31084112	0.86	NPY4R (0.47)	VIPR1VIPR2RXFP1CCNA2CDK2
SCHEMBL29489378	0.86	VIPR1 (0.50)	VIPR1VIPR2GRIN2DGRIN3BGRIN1
SCHEMBL31060878	0.86	ENPEP (0.47)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
CN-116490215-A	Targeted mediated endocytic drug delivery	CRM医疗有限公司	2023-07-25	—	—	CN	disclosed